HEADER HYDROLASE/HYDROLASE INHIBITOR 04-SEP-98 1BUI TITLE STRUCTURE OF THE TERNARY MICROPLASMIN-STAPHYLOKINASE-MICROPLASMIN TITLE 2 COMPLEX: A PROTEINASE-COFACTOR-SUBSTRATE COMPLEX IN ACTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: PLASMINOGEN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: PEPTIDASE S1 CATALYTIC DOMAIN; COMPND 5 SYNONYM: PLASMIN HEAVY CHAIN A, ACTIVATION PEPTIDE, ANGIOSTATIN, COMPND 6 PLASMIN HEAVY CHAIN A, SHORT FORM, PLASMIN LIGHT CHAIN B; COMPND 7 EC: 3.4.21.7; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: STAPHYLOKINASE; COMPND 11 CHAIN: C; COMPND 12 SYNONYM: SAK42D SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PLG; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: STAPHYLOCOCCUS PHAGE 42D.M; SOURCE 10 ORGANISM_TAXID: 10715 KEYWDS PLASMIN, STAPHYLOKINASE, SERINE PROTEINASE, FIBRINOLYSIS, COFACTOR, KEYWDS 2 HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.A.A.PARRY,C.FERNANDEZ-CATALAN,A.BERGNER,R.HUBER,K.HOPFNER, AUTHOR 2 B.SCHLOTT,K.GUEHRS,W.BODE REVDAT 6 09-AUG-23 1BUI 1 REMARK SEQADV LINK REVDAT 5 05-APR-17 1BUI 1 REMARK REVDAT 4 13-JUL-11 1BUI 1 VERSN REVDAT 3 24-FEB-09 1BUI 1 VERSN REVDAT 2 01-APR-03 1BUI 1 JRNL REVDAT 1 02-SEP-99 1BUI 0 JRNL AUTH M.A.PARRY,C.FERNANDEZ-CATALAN,A.BERGNER,R.HUBER,K.P.HOPFNER, JRNL AUTH 2 B.SCHLOTT,K.H.GUHRS,W.BODE JRNL TITL THE TERNARY MICROPLASMIN-STAPHYLOKINASE-MICROPLASMIN COMPLEX JRNL TITL 2 IS A PROTEINASE-COFACTOR-SUBSTRATE COMPLEX IN ACTION. JRNL REF NAT.STRUCT.BIOL. V. 5 917 1998 JRNL REFN ISSN 1072-8368 JRNL PMID 9783753 JRNL DOI 10.1038/2359 REMARK 2 REMARK 2 RESOLUTION. 2.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 18879 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.287 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.000 REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4679 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 25 REMARK 3 SOLVENT ATOMS : 313 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.814 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1BUI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-JUL-99. REMARK 100 THE DEPOSITION ID IS D_1000007318. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-MAY-98 REMARK 200 TEMPERATURE (KELVIN) : 190 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : MPG/DESY, HAMBURG REMARK 200 BEAMLINE : BW6 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.06 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28745 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.650 REMARK 200 RESOLUTION RANGE LOW (A) : 10.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 2.000 REMARK 200 R MERGE (I) : 0.07500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRIES 1FAX AND 2SAK REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 67.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.42 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 7.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 162.01500 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 38.07000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 38.07000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 243.02250 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 38.07000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 38.07000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 81.00750 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 38.07000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 38.07000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 243.02250 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 38.07000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 38.07000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 81.00750 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 162.01500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A -5 REMARK 465 ALA A -4 REMARK 465 ARG A 15 REMARK 465 ALA B -5 REMARK 465 ARG B 15 REMARK 465 VAL C 9 REMARK 465 LEU C 10 REMARK 465 LYS C 11 REMARK 465 GLY C 12 REMARK 465 ASP C 13 REMARK 465 ASP C 14 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PRO A -3 CG CD REMARK 470 PHE A -1 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 3 CG CD CE NZ REMARK 470 LYS A 9 CG CD CE NZ REMARK 470 LYS A 10 CB CG CD CE NZ REMARK 470 LYS A 166 CG CD CE NZ REMARK 470 ARG A 243 CG CD NE CZ NH1 NH2 REMARK 470 ALA B -4 CB REMARK 470 PRO B -3 CB CG CD REMARK 470 GLY B 14 C REMARK 470 GLU B 73 CG CD OE1 OE2 REMARK 470 GLU B 84 CG CD OE1 OE2 REMARK 470 THR B 144 OG1 CG2 REMARK 470 LYS B 166 CG CD CE NZ REMARK 470 TYR B 170A CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLU B 180 CG CD OE1 OE2 REMARK 470 THR B 188A CB OG1 CG2 REMARK 470 SER B 190 CB OG REMARK 470 GLU B 203 CG CD OE1 OE2 REMARK 470 ARG B 221A CB CG CD NE CZ NH1 NH2 REMARK 470 ALA C 15 CB REMARK 470 TYR C 17 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS C 35 CG CD CE NZ REMARK 470 LYS C 50 CG CD CE NZ REMARK 470 ALA C 72 CB REMARK 470 ARG C 77 CG CD NE CZ NH1 NH2 REMARK 470 GLU C 108 CG CD OE1 OE2 REMARK 470 LYS C 109 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO B 13 C - N - CA ANGL. DEV. = 9.2 DEGREES REMARK 500 PHE C 18 N - CA - C ANGL. DEV. = 17.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 0 -142.02 -156.17 REMARK 500 CYS A 1 110.21 65.12 REMARK 500 LYS A 9 -162.42 -62.18 REMARK 500 LYS A 10 108.80 -166.31 REMARK 500 PRO A 24 108.02 -52.87 REMARK 500 HIS A 25 16.96 91.27 REMARK 500 PHE A 37 48.61 36.04 REMARK 500 THR A 54 -154.87 -131.30 REMARK 500 LYS A 60A -76.14 -55.64 REMARK 500 HIS A 71 -34.76 -136.16 REMARK 500 ASN A 75 76.05 61.63 REMARK 500 PRO A 126 143.19 -38.77 REMARK 500 ASN A 127 3.29 54.72 REMARK 500 ALA A 131 -170.72 -45.82 REMARK 500 ASP A 132 -77.67 -80.21 REMARK 500 TRP A 141 33.82 -92.22 REMARK 500 GLU A 143 -162.85 -60.43 REMARK 500 THR A 144 178.21 178.99 REMARK 500 PHE A 150 -55.85 -1.59 REMARK 500 ALA A 152 -89.58 -167.58 REMARK 500 PHE A 171 -112.86 -87.11 REMARK 500 ASP A 189 168.37 176.91 REMARK 500 SER A 195 136.89 -39.99 REMARK 500 LYS A 204 -68.24 78.77 REMARK 500 SER A 214 -59.27 -132.10 REMARK 500 SER B -2 -108.84 51.57 REMARK 500 PHE B -1 86.75 -151.18 REMARK 500 ASP B 0 -97.15 -63.92 REMARK 500 CYS B 1 140.79 179.87 REMARK 500 CYS B 11 114.85 -170.08 REMARK 500 PRO B 13 80.43 -55.03 REMARK 500 HIS B 40 160.58 -40.96 REMARK 500 PHE B 41 -27.46 -173.52 REMARK 500 SER B 60B 128.08 84.67 REMARK 500 SER B 62 36.53 -83.83 REMARK 500 HIS B 71 -40.83 -137.68 REMARK 500 VAL B 74 -91.76 -78.49 REMARK 500 LEU B 76 116.83 67.59 REMARK 500 PRO B 78 -106.35 -51.04 REMARK 500 HIS B 79 98.05 -56.60 REMARK 500 ASP B 102 5.57 172.34 REMARK 500 PRO B 126 130.63 -37.66 REMARK 500 ASN B 127 13.12 54.19 REMARK 500 ARG B 133 -1.73 76.53 REMARK 500 GLU B 143 172.29 39.07 REMARK 500 THR B 144 -115.21 -177.93 REMARK 500 GLN B 145 42.71 -72.01 REMARK 500 ALA B 152 -6.87 59.43 REMARK 500 ALA B 158 109.60 -176.96 REMARK 500 ILE B 163 -102.94 -75.16 REMARK 500 REMARK 500 THIS ENTRY HAS 82 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR A 228 0.08 SIDE CHAIN REMARK 500 TYR B 228 0.07 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 THE UNBOUND FORM OF THE INHIBITOR IS GLU-GLY-ARG-CMK- REMARK 600 CHLOROMETHYLKETONE. UPON REACTION WITH PROTEIN IT FORMS TWO REMARK 600 COVALENT BONDS: 1) A COVALENT BOND TO SER 195 FORMING A HEMIKETAL REMARK 600 AR7 AND 2) A COVALENT BOND TO NE2 OF HIS 57. REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR REMARK 630 MOLECULE NAME: L-ALPHA-GLUTAMYL-N-{(1S)-4-{[AMINO(IMINIO)METHYL] REMARK 630 AMINO}-1-[(1S)-2-CHLORO-1-HYDROXYETHYL]BUTYL}GLYCINAMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 0GJ A 246 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: GLU GLY AR7 0QE REMARK 630 DETAILS: NULL REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: DSSP REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: DSSP REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: ASA REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: CATALYTIC SITE OF CHAIN A REMARK 800 REMARK 800 SITE_IDENTIFIER: ASB REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: CATALYTIC SITE OF CHAIN B REMARK 800 REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0GJ A 246 DBREF 1BUI A -5 245 UNP P00747 PLMN_HUMAN 561 810 DBREF 1BUI B -5 245 UNP P00747 PLMN_HUMAN 561 810 DBREF 1BUI C 11 136 UNP P15240 SAK_BPP42 38 163 SEQADV 1BUI VAL C 9 UNP P15240 EXPRESSION TAG SEQADV 1BUI LEU C 10 UNP P15240 EXPRESSION TAG SEQADV 1BUI SER C 34 UNP P15240 GLY 61 CONFLICT SEQADV 1BUI GLY C 36 UNP P15240 ARG 63 CONFLICT SEQADV 1BUI HIS C 43 UNP P15240 ARG 70 CONFLICT SEQRES 1 A 250 ALA ALA PRO SER PHE ASP CYS GLY LYS PRO GLN VAL GLU SEQRES 2 A 250 PRO LYS LYS CYS PRO GLY ARG VAL VAL GLY GLY CYS VAL SEQRES 3 A 250 ALA HIS PRO HIS SER TRP PRO TRP GLN VAL SER LEU ARG SEQRES 4 A 250 THR ARG PHE GLY MET HIS PHE CYS GLY GLY THR LEU ILE SEQRES 5 A 250 SER PRO GLU TRP VAL LEU THR ALA ALA HIS CYS LEU GLU SEQRES 6 A 250 LYS SER PRO ARG PRO SER SER TYR LYS VAL ILE LEU GLY SEQRES 7 A 250 ALA HIS GLN GLU VAL ASN LEU GLU PRO HIS VAL GLN GLU SEQRES 8 A 250 ILE GLU VAL SER ARG LEU PHE LEU GLU PRO THR ARG LYS SEQRES 9 A 250 ASP ILE ALA LEU LEU LYS LEU SER SER PRO ALA VAL ILE SEQRES 10 A 250 THR ASP LYS VAL ILE PRO ALA CYS LEU PRO SER PRO ASN SEQRES 11 A 250 TYR VAL VAL ALA ASP ARG THR GLU CYS PHE ILE THR GLY SEQRES 12 A 250 TRP GLY GLU THR GLN GLY THR PHE GLY ALA GLY LEU LEU SEQRES 13 A 250 LYS GLU ALA GLN LEU PRO VAL ILE GLU ASN LYS VAL CYS SEQRES 14 A 250 ASN ARG TYR GLU PHE LEU ASN GLY ARG VAL GLN SER THR SEQRES 15 A 250 GLU LEU CYS ALA GLY HIS LEU ALA GLY GLY THR ASP SER SEQRES 16 A 250 CYS GLN GLY ASP SER GLY GLY PRO LEU VAL CYS PHE GLU SEQRES 17 A 250 LYS ASP LYS TYR ILE LEU GLN GLY VAL THR SER TRP GLY SEQRES 18 A 250 LEU GLY CYS ALA ARG PRO ASN LYS PRO GLY VAL TYR VAL SEQRES 19 A 250 ARG VAL SER ARG PHE VAL THR TRP ILE GLU GLY VAL MET SEQRES 20 A 250 ARG ASN ASN SEQRES 1 B 250 ALA ALA PRO SER PHE ASP CYS GLY LYS PRO GLN VAL GLU SEQRES 2 B 250 PRO LYS LYS CYS PRO GLY ARG VAL VAL GLY GLY CYS VAL SEQRES 3 B 250 ALA HIS PRO HIS SER TRP PRO TRP GLN VAL SER LEU ARG SEQRES 4 B 250 THR ARG PHE GLY MET HIS PHE CYS GLY GLY THR LEU ILE SEQRES 5 B 250 SER PRO GLU TRP VAL LEU THR ALA ALA HIS CYS LEU GLU SEQRES 6 B 250 LYS SER PRO ARG PRO SER SER TYR LYS VAL ILE LEU GLY SEQRES 7 B 250 ALA HIS GLN GLU VAL ASN LEU GLU PRO HIS VAL GLN GLU SEQRES 8 B 250 ILE GLU VAL SER ARG LEU PHE LEU GLU PRO THR ARG LYS SEQRES 9 B 250 ASP ILE ALA LEU LEU LYS LEU SER SER PRO ALA VAL ILE SEQRES 10 B 250 THR ASP LYS VAL ILE PRO ALA CYS LEU PRO SER PRO ASN SEQRES 11 B 250 TYR VAL VAL ALA ASP ARG THR GLU CYS PHE ILE THR GLY SEQRES 12 B 250 TRP GLY GLU THR GLN GLY THR PHE GLY ALA GLY LEU LEU SEQRES 13 B 250 LYS GLU ALA GLN LEU PRO VAL ILE GLU ASN LYS VAL CYS SEQRES 14 B 250 ASN ARG TYR GLU PHE LEU ASN GLY ARG VAL GLN SER THR SEQRES 15 B 250 GLU LEU CYS ALA GLY HIS LEU ALA GLY GLY THR ASP SER SEQRES 16 B 250 CYS GLN GLY ASP SER GLY GLY PRO LEU VAL CYS PHE GLU SEQRES 17 B 250 LYS ASP LYS TYR ILE LEU GLN GLY VAL THR SER TRP GLY SEQRES 18 B 250 LEU GLY CYS ALA ARG PRO ASN LYS PRO GLY VAL TYR VAL SEQRES 19 B 250 ARG VAL SER ARG PHE VAL THR TRP ILE GLU GLY VAL MET SEQRES 20 B 250 ARG ASN ASN SEQRES 1 C 128 VAL LEU LYS GLY ASP ASP ALA SER TYR PHE GLU PRO THR SEQRES 2 C 128 GLY PRO TYR LEU MET VAL ASN VAL THR GLY VAL ASP SER SEQRES 3 C 128 LYS GLY ASN GLU LEU LEU SER PRO HIS TYR VAL GLU PHE SEQRES 4 C 128 PRO ILE LYS PRO GLY THR THR LEU THR LYS GLU LYS ILE SEQRES 5 C 128 GLU TYR TYR VAL GLU TRP ALA LEU ASP ALA THR ALA TYR SEQRES 6 C 128 LYS GLU PHE ARG VAL VAL GLU LEU ASP PRO SER ALA LYS SEQRES 7 C 128 ILE GLU VAL THR TYR TYR ASP LYS ASN LYS LYS LYS GLU SEQRES 8 C 128 GLU THR LYS SER PHE PRO ILE THR GLU LYS GLY PHE VAL SEQRES 9 C 128 VAL PRO ASP LEU SER GLU HIS ILE LYS ASN PRO GLY PHE SEQRES 10 C 128 ASN LEU ILE THR LYS VAL VAL ILE GLU LYS LYS HET 0GJ A 246 25 HETNAM 0GJ L-ALPHA-GLUTAMYL-N-{(1S)-4-{[AMINO(IMINIO) HETNAM 2 0GJ METHYL]AMINO}-1-[(1S)-2-CHLORO-1- HETNAM 3 0GJ HYDROXYETHYL]BUTYL}GLYCINAMIDE FORMUL 4 0GJ C14 H28 CL N6 O5 1+ FORMUL 5 HOH *313(H2 O) HELIX 1 1 PRO A 61 SER A 63 5 3 HELIX 2 2 ASN A 165 CYS A 168 1 4 HELIX 3 3 VAL A 231 ARG A 233 5 3 HELIX 4 4 VAL A 235 ARG A 243 1 9 HELIX 5 5 ALA B 56 LEU B 59 5 4 HELIX 6 6 PRO B 61 SER B 63 5 3 HELIX 7 7 ASN B 165 CYS B 168 1 4 HELIX 8 8 VAL B 235 MET B 242 1 8 HELIX 9 9 LYS C 57 THR C 71 1 15 SHEET 1 A 4 GLN A 81 GLU A 84 0 SHEET 2 A 4 TYR A 64 LEU A 68 -1 N LEU A 68 O GLN A 81 SHEET 3 A 4 GLN A 30 THR A 35 -1 N ARG A 34 O LYS A 65 SHEET 4 A 4 HIS A 40 THR A 45 -1 N GLY A 44 O VAL A 31 SHEET 1 B 3 TRP A 51 THR A 54 0 SHEET 2 B 3 ALA A 104 LEU A 108 -1 N LEU A 106 O VAL A 52 SHEET 3 B 3 VAL A 85 LEU A 90 -1 N PHE A 89 O LEU A 105 SHEET 1 C 2 GLU A 135 GLY A 140 0 SHEET 2 C 2 LYS A 156 PRO A 161 -1 N LEU A 160 O CYS A 136 SHEET 1 D 4 GLU A 180 ALA A 183 0 SHEET 2 D 4 GLY A 226 VAL A 229 -1 N TYR A 228 O LEU A 181 SHEET 3 D 4 LYS A 206 GLY A 216 -1 N TRP A 215 O VAL A 227 SHEET 4 D 4 PRO A 198 GLU A 203 -1 N GLU A 203 O LYS A 206 SHEET 1 E 7 GLN B 81 GLU B 84 0 SHEET 2 E 7 TYR B 64 LEU B 68 -1 N LEU B 68 O GLN B 81 SHEET 3 E 7 GLN B 30 THR B 35 -1 N ARG B 34 O LYS B 65 SHEET 4 E 7 HIS B 40 SER B 48 -1 N GLY B 44 O VAL B 31 SHEET 5 E 7 TRP B 51 ALA B 55 -1 N LEU B 53 O THR B 45 SHEET 6 E 7 ILE B 103 LEU B 108 -1 N LEU B 106 O VAL B 52 SHEET 7 E 7 VAL B 85 LEU B 90 -1 N PHE B 89 O LEU B 105 SHEET 1 F 4 LYS B 156 PRO B 161 0 SHEET 2 F 4 GLU B 135 GLY B 140 -1 N GLY B 140 O LYS B 156 SHEET 3 F 4 PRO B 198 GLU B 203 -1 N VAL B 200 O PHE B 137 SHEET 4 F 4 LYS B 206 VAL B 212 -1 N GLY B 211 O LEU B 199 SHEET 1 G 2 GLU B 180 ALA B 183 0 SHEET 2 G 2 GLY B 226 VAL B 229 -1 N TYR B 228 O LEU B 181 SHEET 1 H 3 VAL C 45 PRO C 48 0 SHEET 2 H 3 TYR C 24 VAL C 27 -1 N VAL C 27 O VAL C 45 SHEET 3 H 3 GLY C 124 LEU C 127 1 N PHE C 125 O TYR C 24 SHEET 1 I 3 LYS C 130 VAL C 132 0 SHEET 2 I 3 THR C 30 VAL C 32 1 N THR C 30 O VAL C 131 SHEET 3 I 3 GLU C 38 SER C 41 -1 N LEU C 40 O GLY C 31 SHEET 1 J 2 ILE C 87 ASP C 93 0 SHEET 2 J 2 LYS C 98 PHE C 104 -1 N PHE C 104 O ILE C 87 SSBOND 1 CYS A 1 CYS A 122 1555 1555 2.04 SSBOND 2 CYS A 11 CYS A 20 1555 1555 2.03 SSBOND 3 CYS A 42 CYS A 58 1555 1555 2.04 SSBOND 4 CYS A 136 CYS A 201 1555 1555 2.03 SSBOND 5 CYS A 168 CYS A 182 1555 1555 2.02 SSBOND 6 CYS A 191 CYS A 220 1555 1555 2.02 SSBOND 7 CYS B 1 CYS B 122 1555 1555 2.05 SSBOND 8 CYS B 11 CYS B 20 1555 1555 2.02 SSBOND 9 CYS B 42 CYS B 58 1555 1555 2.03 SSBOND 10 CYS B 136 CYS B 201 1555 1555 2.04 SSBOND 11 CYS B 168 CYS B 182 1555 1555 2.03 SSBOND 12 CYS B 191 CYS B 220 1555 1555 2.04 LINK NE2 HIS A 57 C3 0GJ A 246 1555 1555 1.50 LINK OG SER A 195 C2 0GJ A 246 1555 1555 1.38 SITE 1 ASA 3 SER A 195 HIS A 57 ASP A 102 SITE 1 ASB 3 SER B 195 HIS B 57 ASP B 102 SITE 1 AC1 13 HIS A 57 ASP A 189 SER A 190 CYS A 191 SITE 2 AC1 13 GLN A 192 GLY A 193 SER A 195 SER A 214 SITE 3 AC1 13 TRP A 215 GLY A 216 GLY A 219 LYS B 10 SITE 4 AC1 13 HIS C 43 CRYST1 76.140 76.140 324.030 90.00 90.00 90.00 P 43 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013134 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013134 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003086 0.00000